Taiwan FDA Weighs Stricter Controls on Imported GLP-1 Weight Loss Drugs

Taiwan's Food and Drug Administration is evaluating the implementation of more stringent border controls for GLP-1 weight loss medications. This consideration stems from a notable increase in the illegal importation of these drugs, particularly from China and through online platforms. The FDA has issued a public warning, advising against purchasing such products from unverified sources due to potential health and safety risks.